These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 2531626)
21. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. Hoft DF; Lynch RG; Kirchhoff LV J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708 [TBL] [Abstract][Full Text] [Related]
22. A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator. Da Silva AC; Espinoza AG; Taibi A; Ouaissi A; Minoprio P Immunology; 1998 Jun; 94(2):189-96. PubMed ID: 9741340 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease. Kierszenbaum F; Lopez HM; Sztein MB Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517 [TBL] [Abstract][Full Text] [Related]
24. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction? Basso B; Marini V Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621 [TBL] [Abstract][Full Text] [Related]
25. Trypanosoma cruzi: immunological consequences of parasite modification of host cells. Ribeiro Dos Santos R; Hudson L Clin Exp Immunol; 1980 Apr; 40(1):36-41. PubMed ID: 6771080 [TBL] [Abstract][Full Text] [Related]
26. Antigen characterization of vector-borne and cultured metacyclic trypomastigotes of Trypanosoma cruzi. Yoshida N; Teixeira MM; Sbravate CA Rev Inst Med Trop Sao Paulo; 1986; 28(2):80-6. PubMed ID: 3099366 [No Abstract] [Full Text] [Related]
27. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation. La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791 [TBL] [Abstract][Full Text] [Related]
28. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Buckner FS; Wipke BT; Van Voorhis WC Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608 [TBL] [Abstract][Full Text] [Related]
29. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function. Miller MJ; Wrightsman RA; Stryker GA; Manning JE J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953 [TBL] [Abstract][Full Text] [Related]
31. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes. Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442 [TBL] [Abstract][Full Text] [Related]
32. Immunological characterization of antigens released by Trypanosoma cruzi-infected cells. Grijalva MJ; Goodrum KJ; Rowland EC J Parasitol; 1999 Aug; 85(4):663-71. PubMed ID: 10461946 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of Trypanosoma cruzi on the transcription of the p55IL-2R, c-fos, c-myc and CD69 genes in activated human lymphocytes. Kierszenbaum F; Majumder S; Mejia Lopez H; Sztein MB Parasite Immunol; 1995 Apr; 17(4):197-205. PubMed ID: 7624160 [TBL] [Abstract][Full Text] [Related]
34. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4. Merkenschlager M; Altmann DM; Ikeda H J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999 [TBL] [Abstract][Full Text] [Related]
35. Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes. Kierszenbaum F; Moretti E; Sztein MB Immunology; 1991 Oct; 74(2):317-22. PubMed ID: 1748480 [TBL] [Abstract][Full Text] [Related]
36. [Exoantigens of Trypanosoma cruzi. Epitopes reactive against immunoglobulins of patients with Chagas' disease]. Gruppi A; Moretti ER; Basso B; Vottero-Cima E Medicina (B Aires); 1988; 48(2):161-6. PubMed ID: 3148093 [No Abstract] [Full Text] [Related]
37. Effect of Trypanosoma cruzi released antigens binding to non-infected cells on anti-parasite antibody recognition and expression of extracellular matrix components. Pinho RT; Vannier-Santos MA; Alves CR; Marino AP; Castello Branco LR; Lannes-Vieira J Acta Trop; 2002 Aug; 83(2):103-15. PubMed ID: 12088851 [TBL] [Abstract][Full Text] [Related]
39. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts. Nunes MP; Andrade RM; Lopes MF; DosReis GA J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549 [TBL] [Abstract][Full Text] [Related]
40. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Kotner J; Tarleton R Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]